(Total Views: 290)
Posted On: 05/15/2019 8:57:22 AM
Post# of 154901
No mention of the number of patients in the Pivotal Study. Is it safe to assume that number will be negotiated with FDA after the protocol is submitted and received? Or, has Cytodyn proposed a number, but chose to omit it from the PR.
(0)
(0)
